GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PW Medtech Group Ltd (HKSE:01358) » Definitions » PEG Ratio

PW Medtech Group (HKSE:01358) PEG Ratio : 0.63 (As of Jun. 04, 2024)


View and export this data going back to 2013. Start your Free Trial

What is PW Medtech Group PEG Ratio?

PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, PW Medtech Group's PE Ratio without NRI is 10.19. PW Medtech Group's 5-Year EBITDA growth rate is 16.10%. Therefore, PW Medtech Group's PEG Ratio for today is 0.63.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for PW Medtech Group's PEG Ratio or its related term are showing as below:

HKSE:01358' s PEG Ratio Range Over the Past 10 Years
Min: 0.07   Med: 0.26   Max: 1.08
Current: 0.63


During the past 12 years, PW Medtech Group's highest PEG Ratio was 1.08. The lowest was 0.07. And the median was 0.26.


HKSE:01358's PEG Ratio is ranked better than
82.73% of 249 companies
in the Medical Devices & Instruments industry
Industry Median: 1.97 vs HKSE:01358: 0.63

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


PW Medtech Group PEG Ratio Historical Data

The historical data trend for PW Medtech Group's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PW Medtech Group PEG Ratio Chart

PW Medtech Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PEG Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.04 0.12 0.22 0.46

PW Medtech Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PEG Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 - 0.22 - 0.46

Competitive Comparison of PW Medtech Group's PEG Ratio

For the Medical Instruments & Supplies subindustry, PW Medtech Group's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PW Medtech Group's PEG Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's PEG Ratio distribution charts can be found below:

* The bar in red indicates where PW Medtech Group's PEG Ratio falls into.



PW Medtech Group PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

PW Medtech Group's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=10.18691588785/16.10
=0.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


PW Medtech Group  (HKSE:01358) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


PW Medtech Group PEG Ratio Related Terms

Thank you for viewing the detailed overview of PW Medtech Group's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


PW Medtech Group (HKSE:01358) Business Description

Traded in Other Exchanges
Address
Building 1, No. 23 Panlong West Road, Pinggu District, Beijing, CHN, 101204
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.
Executives
Right Faith Holdings Limited 2101 Beneficial owner
Chan Marc 2201 Interest of corporation controlled by you
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Fidelity China Special Situations Plc 2101 Beneficial owner
Cross Mark Limited 2101 Beneficial owner
Liu Yufeng 2201 Interest of corporation controlled by you
Zhang Zaixian 2202 Interest of your spouse

PW Medtech Group (HKSE:01358) Headlines

No Headlines